Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 2/20 | 0.42 |
| ▸ | FFAR2 | O15552 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6504421 | 1.00 | KCNN4 (0.42) | KCNN4FFAR2PTGS2NPY5RHTR2C | |
| SCHEMBL6508783 | 1.00 | KCNN4 (0.42) | KCNN4FFAR2PTGS2NPY5RHTR2C | |
| SCHEMBL10444517 | 0.88 | PTGS2 (0.38) | KCNN4PTGS2HTR2CHTR2AHTR2B | |
| SCHEMBL6511952 | 0.87 | KCNN4 (0.40) | KCNN4PTGS2NPY5RHTR2CHTR2A | |
| SCHEMBL28334494 | 0.86 | KCNN4 (0.40) | KCNN4PTGS2NPY5RHTR2CHTR2A | |
| SCHEMBL6503437 | 0.86 | KCNN4 (0.40) | KCNN4PTGS2NPY5RHTR2CHTR2A | |
| SCHEMBL10444313 | 0.85 | KCNN4 (0.41) | KCNN4PTGS2HTR2CHTR2BTDP1 | |
| SCHEMBL9725044 | 0.83 | KCNN4 (0.32) | KCNN4HTR2CHTR2AHTR2BTDP1 | |
| SCHEMBL9725042 | 0.83 | KCNN4 (0.32) | KCNN4HTR2CHTR2AHTR2BTDP1 | |
| SCHEMBL9725047 | 0.83 | KCNN4 (0.32) | KCNN4HTR2CHTR2AHTR2BTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200029564-A1 | NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLOXIRANE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200029564-A1 | NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLOXIRANE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | US | disclosed |
| EP-3519405-A1 | 5-SUBSTITUTED IMIDAZOLYLMETHYLOXIRANE DERIVATIVES AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2019-08-07 | — | — | EP | disclosed |
| WO-2018060090-A1 | 5-SUBSTITUTED IMIDAZOLYLMETHYLOXIRANE DERIVATIVES AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-04-05 | — | — | WO | disclosed |
| WO-2018060090-A1 | 5-SUBSTITUTED IMIDAZOLYLMETHYLOXIRANE DERIVATIVES AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-04-05 | — | — | WO | disclosed |
| EP-1399437-B1 | METHOD FOR THE PRODUCTION OF TRIAZOLYLMETHYLEPOXIDES | BASF AG (DE) | 2005-01-26 | — | — | EP | disclosed |
| EP-1399437-A1 | METHOD FOR THE PRODUCTION OF TRIAZOLYLMETHYLEPOXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| EP-1395580-A1 | METHOD FOR THE PURIFICATION OF TRIAZOLYLMETHYLEPOXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-10 | — | — | EP | disclosed |
| WO-2002094818-A1 | METHOD FOR THE PRODUCTION OF TRIAZOLYLMETHYLEPOXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002094817-A1 | METHOD FOR THE PURIFICATION OF TRIAZOLYLMETHYLEPOXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-28 | — | — | WO | disclosed |
| EP-0379081-A2 | Process for the preparation of 1-hydroxymethyl oxiranes Z-substituted in position 2 | BASF Aktiengesellschaft (DE) | 1990-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200029564-A1 | NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLOXIRANE DERIVATIVES | PIP5K1B, IPMK, IPO5 | KCNN4 4235/4885FFAR2 3636/4885PTGS2 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.